NCT06503952View on ClinicalTrials.gov

Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study

Not yet recruitingOBSERVATIONAL
Enrollment

340

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

May 30, 2025

Conditions
InfertilitySuccess Rate of Assisted Reproductive TherapySingle Embryo TransferPregnancy OutcomesImmunological ToleranceImmune System
Trial Locations (2)

75012

Hopital des Bluets- centre d'assistance medicale à la procreation, Paris

Hopital des diaconnesse- Centre d'assistance medicale a la procreation, Paris

All Listed Sponsors
lead

Matricelab Innove

OTHER

NCT06503952 - Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study | Biotech Hunter | Biotech Hunter